If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...

Find insight on Top Glove, Ebos and more in the latest Market Talks covering Health Care.

The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long-term weight loss maintenance for adult patients.

Novo Nordisk's exclusive hold on semaglutide - the active ingredient in popular fat-busting GLP-1 jabs such as Wegovy and ...

Choosing between prescription weight management treatments often involves reviewing medicines that work through different ...

FDA clears 7.2 mg version of blockbuster obesity drug as demand for weight-loss treatments continues to surge globally ...

A MUM who battled her weight for most of her life looks 10 years younger and has been freed from a lifetime of food addiction ...

In a significant development for diabetes and obesity care, the patent for semaglutide - the key molecule behind blockbuster ...

Oral Wegovy becomes the first GLP-1 pill indicated for obesity, distinct from Rybelsus, which remains positioned for type 2 diabetes treatment. Daily administration improves acceptability for ...

FDA-approved oral Wegovy (semaglutide) introduces daily administration for chronic weight management, offering weight-loss ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...